/
OTI transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. Our products and services reside under one reporting hierarchy, with commercial and innovation teams, which are part of a single business unit covering multiple product lines.
The business is unprofitable at the operating level (-62.57% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 38.1% YoY. Margins deteriorated 47.4pp alongside, both lines moving the wrong way.
Free cash flow declined 326% versus the prior year, cash generation momentum has weakened. ROIC dropped from -5.14% to -14.60%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
$113M
▼ -38.1% YoY
Net Income (TTM)
-$75M
▼ -252.5% YoY
Op. Margin
-68.56%
▼ -47.4pp YoY
ROIC
-16.88%
▼ -9.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$48M
▼ -325.7% YoY
Op. Cash Flow (TTM)
-$43M
▼ -279.1% YoY
Net Debt
-$164M
Net Cash Position
Cash & Equiv.
$177M
5Y CAGR: -7.7%
Continue Research